Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GoodRx Holdings (GDRX) Stock Price & Analysis
1,096 Followers
GDRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.14 - $9.37
Previous Close$7.56
Volume662.73K
Average Volume (3M)1.37M
Market Cap
$2.92B
Enterprise Value$2.88B
Total Cash (Recent Filing)$672.30M
Total Debt (Recent Filing)$711.07M
Price to Earnings (P/E)―
Beta1.85
Next Earnings
Aug 07, 2024EPS Estimate
$0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding375,205,112
10 Day Avg. Volume1,715,593
30 Day Avg. Volume1,367,482
Standard Deviation0.20
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)13.90
Price to Sales (P/S)0.95
Price to Cash Flow (P/CF)42.70
P/FCF Ratio26.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.83
Enterprise Value/Gross Profit4.21
Enterprise Value/Ebitda42.60
Forecast
1Y Price Target
$9.71Price Target Upside24.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
GoodRx Holdings News
PremiumCompany Announcements
GoodRx Board Revamp: Adam Karol Exits, Simon Patterson Joins
Bulls Say, Bears Say
Bulls Say
Financial GuidanceGoodRx’s 2026 guidance reflects confidence in the Manufacturer Solutions business and growth in ISP, with a plan for revenue reinvestment and debt reduction.
Market LeadershipGoodRx is a category leader continuing to gain market share, resulting in significant cumulative savings since inception.
Strategic RelationshipsGoodRx's relationships with drug manufacturers are strengthening, with an expected increase from 30 to over 100 brands for point-of-sale discounts, indicating potential for significant growth in this area.
Bears Say
Business Model ShiftGoodRx has shifted its contracting model which may weaken the incentive to open the GoodRx app as the Integrated Savings Program becomes less important.
Competition And Growth StrategyPotential channel risks from health plans offering competing discount cards and their own network providers could impact GoodRx's provider network growth.
Regulatory RisksIf regulations move more plans toward a fixed co-pay, the incentive for consumers to use discount Rx cards could decrease, posing a risk to GoodRx's value proposition.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $4.13 and its highest was $9.37 in the past 12 months.
What is GoodRx Holdings’s market cap?
Currently, no data Available
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Aug 07, 2024 which is in 68 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on May 09, 2024. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.072 by $0.008.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is $0.08.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 94,335,790 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, beating expectations of $0.072. Following the earnings report the stock price went down -8.936%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Among the largest hedge funds holding GoodRx Holdings’s share is Silver Lake Group, L.L.C.. It holds GoodRx Holdings’s shares valued at 25M.
---
GoodRx Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.71 (24.97% Upside)
$9.71 (24.97% Upside)
Blogger Sentiment
Neutral
GDRX Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 141.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.70%
12-Months-Change
Fundamentals
Return on Equity
-0.90%
Trailing 12-Months
Asset Growth
-9.78%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.
---
GDRX Earnings Call
Q1 2024
0:00 / 0:00
---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$9.71
▲(24.97% Upside)
Technical Analysis
Best Analysts Covering GDRX
1 Year
1 Year Success Rate
7/8 ratings generated profit
1 Year Average Return
+17.80%
reiterated a buy rating 17 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +17.80% per trade.
---